Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost‐effectiveness analysis

INTRODUCTION: People living with HIV (PLHIV) have an elevated risk of atherosclerotic cardiovascular disease (CVD) compared to their HIV‐negative peers. Expanding statin use may help alleviate this burden. However, the choice of statin in the context of antiretroviral therapy is challenging. Pravast...

Descripción completa

Detalles Bibliográficos
Autores principales: Boettiger, David C, Newall, Anthony T, Chattranukulchai, Pairoj, Chaiwarith, Romanee, Khusuwan, Suwimon, Avihingsanon, Anchalee, Phillips, Andrew, Bendavid, Eran, Law, Matthew G, Kahn, James G, Ross, Jeremy, Bautista‐Arredondo, Sergio, Kiertiburanakul, Sasisopin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Supplement: Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305414/
https://www.ncbi.nlm.nih.gov/pubmed/32562359
http://dx.doi.org/10.1002/jia2.25494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305414/
https://www.ncbi.nlm.nih.gov/pubmed/32562359
http://dx.doi.org/10.1002/jia2.25494

Ejemplares similares